UK’s OMass Therapeutics lands $18 mln in Series A funding round

11/22/2018 11:50:00 AM (GMT)

UK biopharmaceutical company OMass Therapeutics has landed 14 million pounds ($18 million) in a Series A funding round.

The funding round was led by UK investment company Syncona Partners.

OMass Therapeutics plans to use the proceeds to nourish its structural mass spectrometry to identify new medicines and to back pipeline development.

The Series A round also received participation from investment firm Oxford Sciences Innovation.

OMass Technologies

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text